In a follow-up dataset analysis involving individuals diagnosed with cirrhosis (GSE15654), it was observed that patients with hepatocellular carcinoma (HCC) exhibited significantly higher levels of IGF2BP2 expression compared to those without HCC (Fig. 1f). This evidence concerns the gene IGF2BP2 and hepatocellular carcinoma.